Abiopharma

🔍 Pierce James Andrew (Executive)

Company: STRYKER CORP (SYK)

Report Date: 2026-03-09

Detailed Transactions and Holdings:

• Acquired 14,912 shares of Common Stock (Direct)
  Date: 2026-03-09 | Code: A | equity_swap_involved: 0 | shares_owned_after: 88,246.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-09 | Code: H | nature_of_ownership: By Son GP | shares_owned_after: 712.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-09 | Code: H | nature_of_ownership: By Son AP | shares_owned_after: 713.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-09 | Code: H | nature_of_ownership: By 401K | shares_owned_after: 1,595.00

Footnotes:

• F1: Acquired upon the achievement of pre-established three-year adjusted diluted net earnings per share goals and sales performance goals. The earned shares vest on March 21, 2026.